Algert Global LLC Chroma Dex Corp. Transaction History

Algert Global LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	SELL	$1.19 - $2.06 $34,272 - $59,328	-28,800 Reduced 70.99%	11,770 $14,000
Q2 2022 Aug 15, 2022	BUY	$1.59 - $2.7 $10,319 - $17,523	6,490 Added 19.04%	40,570 $68,000
Q1 2022 May 16, 2022	BUY	$2.02 - $3.92 $68,841 - $133,593	34,080 New	34,080 $84,000
Q3 2021 Nov 15, 2021	SELL	$6.05 - $10.41 $72,781 - $125,232	-12,030 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$6.66 - $10.92 $80,119 - $131,367	12,030 New	12,030 $119,000
Q1 2021 May 14, 2021	SELL	$4.59 - $18.74 $125,490 - $512,351	-27,340 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$3.0 - $5.52 $1,830 - $3,367	-610 Reduced 2.18%	27,340 $125,000
Q1 2020 May 13, 2020	BUY	$2.54 - $4.75 $70,993 - $132,762	27,950 New	27,950 $91,000

17.2M

66.7K

8.2K

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $375M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.